OrthoPediatrics Corp
KIDS
View Detailed Chart
20.110USD
+0.860+4.47%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
504.21MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+4.47%
5 Days
-1.08%
1 Month
+4.74%
6 Months
-20.89%
Year to Date
-13.24%
1 Year
-33.10%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-18Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Buy
Current Rating
33.857
Target Price
+75.88%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 67.41% year-on-year.
Overvalued
The company’s latest PE is -11.18, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 26.06M shares, decreasing 3.62% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 947.10K shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.
Ticker SymbolKIDS
CompanyOrthoPediatrics Corp
CEOMr. David R. Bailey
Websitehttps://www.orthopediatrics.com/
Related Instruments
+0.30%
+0.25%
+1.07%
+0.61%
+0.43%
+2.29%
+0.76%
-0.86%
+0.69%
+3.50%
+0.29%
-0.65%
-0.75%
+4.51%
+0.41%
+2.11%
+0.57%
+2.42%
+1.75%
+1.25%
